vs
Side-by-side financial comparison of Bolt Biotherapeutics, Inc. (BOLT) and US ENERGY CORP (USEG). Click either name above to swap in a different company.
Bolt Biotherapeutics, Inc. is the larger business by last-quarter revenue ($2.5M vs $1.7M, roughly 1.4× US ENERGY CORP). US ENERGY CORP runs the higher net margin — -192.2% vs -265.2%, a 73.0% gap on every dollar of revenue. Over the past eight quarters, Bolt Biotherapeutics, Inc.'s revenue compounded faster (-31.2% CAGR vs -51.3%).
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in immune-stimulating antibody conjugate (ISAC) therapies for cancer treatment. Its core pipeline targets hard-to-treat solid tumors, serving global oncology markets and advancing novel immunotherapies that trigger targeted anti-tumor immune responses to improve patient outcomes.
NextEra Energy, Inc. is an American energy company that is the world's largest electric utility holding company by market capitalization, with a valuation of over $170 billion as of Oct 2024. NextEra Energy had revenues of $24.8 billion and 16,700 employees throughout the US and Canada in 2024. It has a current generating capacity of 73 gigawatts. Its subsidiaries include Florida Power & Light (FPL), NextEra Energy Resources (NEER), XPLR Energy Partners, and NextEra Energy Services.
BOLT vs USEG — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5M | $1.7M |
| Net Profit | $-6.6M | $-3.3M |
| Gross Margin | — | — |
| Operating Margin | -283.4% | -194.4% |
| Net Margin | -265.2% | -192.2% |
| Revenue YoY | — | -64.9% |
| Net Profit YoY | 58.4% | -48.7% |
| EPS (diluted) | $-9.38 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5M | — | ||
| Q3 25 | $2.2M | $1.7M | ||
| Q2 25 | $1.8M | $2.0M | ||
| Q1 25 | $1.2M | $2.2M | ||
| Q4 24 | $0 | $4.2M | ||
| Q3 24 | $1.1M | $5.0M | ||
| Q2 24 | $1.3M | $6.0M | ||
| Q1 24 | $5.3M | $5.4M |
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $-7.1M | $-3.3M | ||
| Q2 25 | $-8.6M | $-6.1M | ||
| Q1 25 | $-11.0M | $-3.1M | ||
| Q4 24 | $-15.9M | — | ||
| Q3 24 | $-15.2M | $-2.2M | ||
| Q2 24 | $-21.2M | $-2.0M | ||
| Q1 24 | $-10.8M | $-9.5M |
| Q4 25 | -283.4% | — | ||
| Q3 25 | -355.1% | -194.4% | ||
| Q2 25 | -510.5% | -307.6% | ||
| Q1 25 | -991.4% | -140.8% | ||
| Q4 24 | — | -278.9% | ||
| Q3 24 | -1441.1% | -83.8% | ||
| Q2 24 | -1772.3% | -28.4% | ||
| Q1 24 | -324.1% | -148.8% |
| Q4 25 | -265.2% | — | ||
| Q3 25 | -329.4% | -192.2% | ||
| Q2 25 | -474.6% | -298.7% | ||
| Q1 25 | -903.4% | -141.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1330.1% | -45.3% | ||
| Q2 24 | -1662.4% | -32.6% | ||
| Q1 24 | -205.0% | -176.9% |
| Q4 25 | $-9.38 | — | ||
| Q3 25 | $-3.72 | — | ||
| Q2 25 | $-4.46 | $-0.19 | ||
| Q1 25 | $-0.29 | — | ||
| Q4 24 | $-13.73 | $-0.42 | ||
| Q3 24 | $-7.93 | $-0.08 | ||
| Q2 24 | $-11.12 | $-0.08 | ||
| Q1 24 | $-0.28 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.5M | $1.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $26.5M | $25.0M |
| Total Assets | $56.7M | $46.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.5M | — | ||
| Q3 25 | $31.9M | $1.7M | ||
| Q2 25 | $34.8M | $6.9M | ||
| Q1 25 | $38.8M | $10.6M | ||
| Q4 24 | $47.3M | $7.9M | ||
| Q3 24 | $53.8M | $1.3M | ||
| Q2 24 | $73.7M | $2.4M | ||
| Q1 24 | $91.3M | $2.2M |
| Q4 25 | $26.5M | — | ||
| Q3 25 | $32.1M | $25.0M | ||
| Q2 25 | $38.8M | $28.0M | ||
| Q1 25 | $46.8M | $33.6M | ||
| Q4 24 | $57.2M | $24.2M | ||
| Q3 24 | $72.0M | $35.7M | ||
| Q2 24 | $85.9M | $37.7M | ||
| Q1 24 | $104.2M | $36.7M |
| Q4 25 | $56.7M | — | ||
| Q3 25 | $65.1M | $46.5M | ||
| Q2 25 | $75.5M | $51.0M | ||
| Q1 25 | $85.9M | $55.8M | ||
| Q4 24 | $99.6M | $49.7M | ||
| Q3 24 | $109.3M | $64.1M | ||
| Q2 24 | $124.2M | $73.7M | ||
| Q1 24 | $142.9M | $70.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.2M | $-155.0K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.2M | — | ||
| Q3 25 | $-9.7M | $-155.0K | ||
| Q2 25 | $-9.6M | $-1.6M | ||
| Q1 25 | $-13.4M | $-4.5M | ||
| Q4 24 | $-14.4M | $1.7M | ||
| Q3 24 | $-14.0M | $2.6M | ||
| Q2 24 | $-16.1M | $929.0K | ||
| Q1 24 | $-16.8M | $-603.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-14.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1227.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BOLT
Segment breakdown not available.
USEG
| Oil Sales | $1.6M | 91% |
| Other | $151.0K | 9% |
